Literature DB >> 14724300

Influenza vaccine--outmaneuvering antigenic shift and drift.

John Treanor1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14724300     DOI： 10.1056/NEJMp038238

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  64 in total

1.  The memory phase of the CD4 T-cell response to influenza virus infection maintains its diverse antigen specificity.

Authors:  Katherine A Richards; Francisco A Chaves; Andrea J Sant
Journal:  Immunology       Date:  2011-03-29       Impact factor: 7.397

2.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Authors:  Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

3.  Mortality in children from influenza and respiratory syncytial virus.

Authors:  Douglas M Fleming; Rachel S Pannell; Kenneth W Cross
Journal:  J Epidemiol Community Health       Date:  2005-07       Impact factor: 3.710

4.  Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum.

Authors:  Alison P Galvani; Timothy C Reluga; Gretchen B Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-16       Impact factor: 11.205

5.  Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution.

Authors:  Arthur Chun-Chieh Shih; Tzu-Chang Hsiao; Mei-Shang Ho; Wen-Hsiung Li
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-29       Impact factor: 11.205

6.  Quadrivalent influenza vaccine in the United States.

Authors:  Manika Suryadevara; Joseph B Domachowske
Journal:  Hum Vaccin Immunother       Date:  2013-11-14       Impact factor: 3.452

7.  Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan.

Authors:  Shin-Ru Shih; Guang-Wu Chen; Ching-Chun Yang; Weng-Zhi Yang; Ding-Ping Liu; Jih-Hui Lin; Shu-Chun Chiu; Haur-Young Chen; Kuo-Chien Tsao; Chung-Guei Huang; Ya-Ling Huang; Chee-Keng Mok; Chi-Jene Chen; Tzou-Yien Lin; Jen-Ren Wang; Chuan-Liang Kao; Kwei-Hsian Lin; Li-Kuang Chen; Hock-Liew Eng; Yung-Ching Liu; Po-Yen Chen; Jen-Shiou Lin; Jen-Hsien Wang; Cheng-Wen Lin; Yu-Jiun Chan; Jang-Jih Lu; Chao A Hsiung; Pei-Jer Chen; Ih-Jen Su
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

8.  Imperfect vaccine and hysteresis.

Authors:  Xingru Chen; Feng Fu
Journal:  Proc Biol Sci       Date:  2019-01-16       Impact factor: 5.349

9.  Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents.

Authors:  Vincenzo Baldo; Tatjana Baldovin; Michele Pellegrini; Gabriele Angiolelli; Silvia Majori; Annarosa Floreani; Marta Cecilia Busana; Chiara Bertoncello; Renzo Trivello
Journal:  Clin Dev Immunol       Date:  2010-03-29

10.  A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America.

Authors:  Alexander L Greninger; Eunice C Chen; Taylor Sittler; Alex Scheinerman; Nareg Roubinian; Guixia Yu; Edward Kim; Dylan R Pillai; Cyril Guyard; Tony Mazzulli; Pavel Isa; Carlos F Arias; John Hackett; Gerald Schochetman; Steve Miller; Patrick Tang; Charles Y Chiu
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.